α‐Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies

Conclusions: CSF α‐synuclein species could be useful as part of a biomarker panel for dementia with Lewy bodies. Evaluating both oligomeric α‐synuclein and total α‐synuclein in CSF helps in the diagnosis of dementia with Lewy bodies. © 2018 The Authors.Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Source: Movement Disorders - November 15, 2018 Category: Neurology Authors: Inger Steenoven, Nour K. Majbour, Nishant N. Vaikath, Henk W. Berendse, Wiesje M. Flier, Wilma D.J. Berg, Charlotte E. Teunissen, Afina W. Lemstra, Omar M.A. El ‐Agnaf Tags: Research Article Source Type: research